SCHEMBL735588

SCHEMBL735588

CN(C)C1(c2ccccc2)CC=C(c2[nH]c3ccccc3c2CCN2CCCCC2)CC1

nearest known ligand 0.55

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.55
HTR2C P28335 4/20 0.55
DRD2 P14416 3/20 0.55
OPRM1 P35372 8/20 0.44
OPRL1 P41146 6/20 0.44
CHRNA7 P36544 1/20 0.38
OGFRL1 Q5TC84 4/20 0.38
BCHE P06276 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
HDAC1 Q13547 1/20 0.36
OPRD1 P41143 1/20 0.36
OPRK1 P41145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL733107 0.99 HTR2A (0.55) HTR2AHTR2CDRD2OPRM1OPRL1
SCHEMBL735511 0.92 HTR2A (0.46) HTR2AHTR2CDRD2OPRM1OPRL1
SCHEMBL734860 0.91 HTR2A (0.44) HTR2AHTR2CDRD2OPRM1OPRL1
SCHEMBL735995 0.90 OPRM1 (0.46) HTR2AHTR2CDRD2OPRM1OPRL1
Citric Acid SCHEMBL3165180 0.89 HTR2A (0.45) HTR2AHTR2CDRD2OPRM1OPRL1
SCHEMBL733706 0.89 OPRM1 (0.47) HTR2AHTR2CDRD2OPRM1OPRL1
SCHEMBL735786 0.89 OPRM1 (0.42) HTR2AHTR2CDRD2OPRM1OPRL1
SCHEMBL735054 0.87 KDM4E (0.45) HTR2AHTR2CDRD2OPRM1OPRL1
SCHEMBL735977 0.87 OPRM1 (0.41) HTR2AHTR2CDRD2OPRM1OPRL1
SCHEMBL735512 0.85 OPRM1 (0.44) HTR2AHTR2CDRD2OPRM1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP claimed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US claimed
EP-2044016-B1 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM GRUENENTHAL GMBH (DE) 2012-12-05 EP disclosed
US-8138187-B2 Substituted heteroaryl derivatives GRUENENTHAL GMBH (DE) 2012-03-20 US disclosed
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES GRUNENTHAL GMBH (DE) 2010-01-14 US disclosed
EP-2044016-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1-AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2009-04-08 EP disclosed
WO-2008009415-A2 4-HETEROARYL-SUBSTITUTED 1-AMINOCYCLOHEXANE-1- AND CYCLOHEXENE-1-DERIVATIVES HAVING EFFECTS ON THE OPIOD RECEPTOR SYSTEM Grünenthal GmbH (DE) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009986-A1 SUBSTITUTED HETEROARYL DERIVATIVES CYP3A43, HMGCR, ABCG2 HTR2A 238/4885HTR2C 118/4885DRD2 553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.